Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Disease; Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01330342
What this trial is testing

Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma

Who this might be right for
HIVLymphoma
St Stephens Aids Trust 40
Not applicableStudy completedNCT05510908
What this trial is testing

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Who this might be right for
HIV-Associated Malignant NeoplasmHIV InfectionsCancer+5 more
AIDS Malignancy Consortium 460
Testing effectiveness (Phase 2)UnknownNCT00003942
What this trial is testing

Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Systemix 15
Testing effectiveness (Phase 2)Looking for participantsNCT05907759
What this trial is testing

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Who this might be right for
Lymphoma, Primary Effusion
National Cancer Institute (NCI) 28
Early research (Phase 1)WithdrawnNCT02657447
What this trial is testing

Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)

Who this might be right for
Non-Hodgkin Lymphoma
Nordic Nanovector
Large-scale testing (Phase 3)Not Yet RecruitingNCT07647432
What this trial is testing

HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV

Who this might be right for
Plasmablastic LymphomaHivConsolidation
University of Illinois at Chicago 17
Testing effectiveness (Phase 2)Study completedNCT03593187
What this trial is testing

A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma

Who this might be right for
HIV-1 Infection
Assistance Publique - Hôpitaux de Paris 2
Testing effectiveness (Phase 2)Study completedNCT00006264
What this trial is testing

Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium
Not applicableStudy completedNCT00982449
What this trial is testing

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Who this might be right for
Hodgkin LymphomaNon Hodgkin LymphomaKaposi's Sarcoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Not applicableStudy completedNCT00226304
What this trial is testing

Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma

Who this might be right for
HIV InfectionsLymphoma, AIDS-Related
National Institutes of Health Clinical Center (CC) 120
Testing effectiveness (Phase 2)Ended earlyNCT00126243
What this trial is testing

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma

Who this might be right for
AIDS Related Lymphoma
French National Agency for Research on AIDS and Viral Hepatitis 60
Early research (Phase 1)Study completedNCT00002936
What this trial is testing

Altretamine and Etoposide in Treating Patients With HIV-Related Cancer

Who this might be right for
LymphomaSarcoma
Roswell Park Cancer Institute
Not applicableLooking for participantsNCT05663502
What this trial is testing

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Who this might be right for
Anal CarcinomaHematopoietic and Lymphoid Cell NeoplasmHIV Infection+9 more
AIDS Malignancy Consortium 200
Testing effectiveness (Phase 2)Study completedNCT00392990
What this trial is testing

Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma

Who this might be right for
Lymphoma
Northwestern University 25
Post-approval studies (Phase 4)Study completedNCT00466258
What this trial is testing

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Who this might be right for
HIV InfectionsDiffuse Large B Cell Lymphoma
PETHEMA Foundation 50
Not applicableUnknownNCT03267407
What this trial is testing

Vietnam Cryptococcal Retention in Care Study - Version 2.1

Who this might be right for
HIV/AIDSCryptococcal MeningitisOpportunistic Infections, HIV Related+3 more
National Hospital for Tropical Diseases, Hanoi, Vietnam 1,184
Testing effectiveness (Phase 2)Study completedNCT00002621
What this trial is testing

Interferon Alfa in Treating Children With HIV-Related Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 8
Early research (Phase 1)Looking for participantsNCT04902443
What this trial is testing

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

Who this might be right for
Viral Associated MalignanciesKaposi SarcomaEBV/KSHV-associated Lymphomas
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)WithdrawnNCT00024128
What this trial is testing

Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium
Very early researchLooking for participantsNCT04139304
What this trial is testing

Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Who this might be right for
Plasmablastic LymphomaAnn Arbor Stage I Diffuse Large B-Cell LymphomaAnn Arbor Stage II Diffuse Large B-Cell Lymphoma+2 more
AIDS Malignancy Consortium 15
Next Page